Aplagon Doses First Patient in APAC Ph 2a Trial for PAOD/CLTI
13 Mar 2026 //
PHARMIWEB
Aplagon Doses First Patient in Phase 2a APAC Trial for PAOD/CLTI
12 Mar 2026 //
GLOBENEWSWIRE
Aplagon Secure 7M to Advance APAC for Thrombo-Inflammatory Diseases
03 Feb 2025 //
GLOBENEWSWIRE
Aplagon secures EUR 7 million for APAC phase 2a trials
03 Feb 2025 //
PHARMATIMES

Market Place
Sourcing Support